RESEARCH ARTICLE


Are We Economically Efficient Enough to Increase the Potential of in Vitro Proliferation of Osteoblasts by Means of Pharmacochemical Agents?



Mehmet Isyar1, Seyit Ali Gumustas2, Ibrahim Yilmaz3, *, Duygu Yasar Sirin4, Hacı Bayram Tosun5, Mahir Mahirogullari1
1 Department of Orthopaedic and Traumatology, Istanbul Medipol University School of Medicine, 34214, Istanbul, Turkey
2 General Secretariat of the Public Hospitals Union, Republic of Turkey, Ministry of Health, 59100, Tekirdag, Turkey
3 Department of Pharmacovigilance, Materiovigilance and Rational Use of Drugs, State Hospital, Republic of Turkey, Ministry of Health, 59100, Tekirdag, Turkey
4 Department of Molecular Biology and Genetic, Namik Kemal University, Faculty of Arts and Sciences, 59100, Tekirdag, Turkey
5 Department of Orthopaedics and Traumatology, Adiyaman University School of Medicine, 02000, Adıyaman, Turkey


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 1272
Abstract HTML Views: 1140
PDF Downloads: 221
ePub Downloads: 182
Total Views/Downloads: 2815
Unique Statistics:

Full-Text HTML Views: 804
Abstract HTML Views: 606
PDF Downloads: 157
ePub Downloads: 124
Total Views/Downloads: 1691



© Isyar et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Department of Pharmacovigilance, Materiovigilance and Rational Use of Drugs, State Hospital, Republic of Turkey, Ministry of Health, 59100, Tekirdag, Turkey; Tel: +9053 2701 2858; Fax: +902822625355; E-mail: ibrahimyilmaz77@yahoo.com


Abstract

Background:

The aim of this study was to test the necessity of using expensive and unaccesible pharmacological-chemical agents in the proliferation of bone tissue cultures and in the induction of mineralized matrix formation to increase the osteogenic effect.

Methods:

For this purpose, human primary cell cultures were prepared and then divided into two groups. Whereas the cells in group I were fed with an osteoblast stimulator medium containing Dulbecco’s Modified Eagle Medium (DMEM) and β-glycerophosphate, the cells in group II were fed with DMEM containing dexamethasone and 2-phospho-L-ascorbic acid trisodium salt. Both groups were evaluated in terms of viability, toxicity, and proliferation and then compared in terms of cell surface morphology through inverted light and environmental scanning electron microscopy. In addition to immunoflow cytometric analyses, the effects of alkaline phosphatase activities were evaluated using the spectrophotometric method to examine the osteoblastic activities. Costs were calculated in the currency of the European Union (Euros). The Tukey Honestly Significant Difference test was used to reach the statistical evaluation of the data after the analysis of variance.

Results:

It was reported that the level of the alkaline phosphates was higher in group I compared to group II. It was observed that the surface morphology quality, the number of living cells, and proliferation were higher in group II and that the results were deemed statistically significant.

Conclusion:

It was found that the 2-phospho-L-ascorbic acid trisodium salt and dexamethasone mixture was as effective as the expensive commercial kits on the osteogenic effect on human primary bone tissue.

Keywords: 2-phospho-l-ascorbic acid trisodium salt, Cell differentiation, Cost effectiveness, Dexamethasone, Osteogenic effect, Proliferation.